Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated completion date for the primary phase of the clinical trial study regarding the treatment of low-grade glioma in children and young adults.
    Difference
    0.0%
    Check dated 2024-05-14T05:08:48.000Z thumbnail image
  6. Check
    8 days ago
    Change Detected
    Summary
    The value '06 Recruiting Contact : Site Public Contact 888-275-3853 Principal Investigator : Jessica M. Sun 03 06' has recently changed to '09 Suspended 08 (Estimated) 09'. This change indicates a shift in the status of the study from recruiting to suspended, possibly affecting the availability of medical and healthcare-related publications and documentation.
    Difference
    0.4%
    Check dated 2024-05-10T12:26:56.000Z thumbnail image
  7. Check
    11 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated completion date for the study, which is now set for 2026-12-30.
    Difference
    0.0%
    Check dated 2024-05-07T21:29:02.000Z thumbnail image
  8. Check
    12 days ago
    Change Detected
    Summary
    The value 02 01 02 has been updated to 06 Toronto, Ontario, Canada, M5G 1X8 Recruiting Hospital for Sick Children. This change likely indicates a new location or contact information related to medical and healthcare research at the Hospital for Sick Children in Toronto.
    Difference
    0.6%
    Check dated 2024-05-06T19:20:07.000Z thumbnail image
  9. Check
    14 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated completion date for the study on the webpage, which focuses on investigating the combination of selumetinib and vinblastine in treating low-grade glioma in children and young adults.
    Difference
    0.0%
    Check dated 2024-05-04T10:10:43.000Z thumbnail image
  10. Check
    15 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '01 Recruiting Contact : Site Public Contact 302-651-5572 Allison.bruce@nemours.org Principal Investigator : Scott M. Bradfield 04 30 01' to '02 Suspended 05 01 02'. This change indicates a shift in the status of the study from recruiting to suspended, possibly affecting the progress of medical and healthcare-related research and documentation.
    Difference
    0.5%
    Check dated 2024-05-03T08:50:49.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.